M&AEconomic Times
Sun Pharma eyes $4B loan for Organon buy
Positive+62
GreyOak summary
Sun Pharma is arranging a $4 billion syndicated loan to refinance part of its $11.75 billion acquisition of US healthcare firm Organon. Five lead banks are finalizing terms for the facility, with additional lenders expected to join. The deal, approved by Organon shareholders, is anticipated to close in late 2026 or early 2027.
What it affects
- Sun Pharmaceutical IndustriesSUNPHARMAPositive +62
Rolling sentiment Positive +17
Source
Read the original at Economic TimesMore Sun Pharmaceutical Industries news
- Deven Choksey prefers Sun Pharma, Cipla for fresh buying; sees upside in Indian ITCNBC-TV18 · Stock view ·